ReviewPharmacoEconomics2004
Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.
Katherine A Lyseng-Williamson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewPharmacoEconomics2004
Katherine A Lyseng-Williamson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.